I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| classical monocyte | 12 studies | 26% ± 15% | |
| natural killer cell | 8 studies | 27% ± 10% | |
| CD16-positive, CD56-dim natural killer cell, human | 7 studies | 28% ± 12% | |
| non-classical monocyte | 7 studies | 33% ± 21% | |
| T cell | 5 studies | 20% ± 6% | |
| epithelial cell | 5 studies | 32% ± 9% | |
| B cell | 4 studies | 26% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 25% ± 10% | |
| mature NK T cell | 4 studies | 25% ± 12% | |
| macrophage | 4 studies | 21% ± 4% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 22% ± 4% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 25% ± 8% | |
| conventional dendritic cell | 3 studies | 36% ± 22% | |
| squamous epithelial cell | 3 studies | 42% ± 20% | |
| monocyte | 3 studies | 22% ± 7% | |
| goblet cell | 3 studies | 19% ± 1% |
